Upgrade to SI Premium - Free Trial

Perma-Fix Reports Results for the Fourth Quarter and Full Year of 2016

March 22, 2017 7:00 AM

ATLANTA, GA -- (Marketwired) -- 03/22/17 -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the "Company") today announced results for the fourth quarter and full year ended December 31, 2016.

Dr. Louis F. Centofanti, Chief Executive Officer, stated, "We achieved $1.9 million of adjusted EBITDA (as defined below) for the fourth quarter of 2016, which exceeded our previously announced expectations. In 2016, we experienced weakness in both the Treatment and Services Segments due to a temporary shift in government priorities. However, based on our sales pipeline and current trends, we expect to achieve growth and improved results in 2017.

"We are bidding on an increased number of projects within our Services Segment and anticipate improved results in 2017 for our Treatment Segment. Despite some weather-related delays, we expect the first quarter of 2017 to be significantly improved compared to the first quarter of last year.

"We are on track to complete the closure of our M&EC facility by January 2018, after which we believe our fixed facility expenses will be reduced by $4-$5 million annually. We are also in the process of replacing the closure policy on our Perma-Fix Northwest facility, which we expect will free up approximately $3.5 million of our restricted finite sinking funds. When this occurs, we will use the funds to reduce debt and increase our borrowing availability. Given our improving sales pipeline and reduced debt we believe we are well positioned heading into 2017."

Dr. Centofanti concluded, "We continue to work towards finalizing an agreement with a private investor to fund our medical subsidiary and hope to have an update in the second quarter."

Financial Results

Revenue for the fourth quarter of 2016 was $13.4 million versus $15.1 million for the same period last year. Revenue from the Services Segment decreased to $4.0 million from $5.5 million for the same period in 2015. Revenue for the Treatment Segment was $9.4 million versus $9.6 for the same period in 2015. The shortfall in revenue was primarily within our Services Segment. Our Services Segment revenues are project based; as such, the scope, duration and completion of each project vary. As a result, our Services revenues are subject to differences relating to timing and project value.

Gross profit for the fourth quarter of 2016 was $3.4 million versus $3.9 million for the fourth quarter of 2015, a decrease of approximately $468,000. The decrease in gross profit was primarily within the Services Segment where gross profit decreased by approximately $558,000 or 44.6% primarily due to the decrease in revenue. Treatment Segment gross profit increased by approximately $90,000.

Operating income for the fourth quarter of 2016 was $402,000 versus operating income of $817,000 for the fourth quarter of 2015. Operating income for the fourth quarter of 2016 and 2015 included research and development ("R&D") costs of approximately $294,000 and $760,000, respectively, for the development of the new medical production technology by our majority-owned Polish subsidiary, Perma-Fix Medical. During the latter part of 2016, our Perma-Fix Medical subsidiary ceased a substantial portion of its R&D activity until it obtains its own credit facility or a new investor funds its R&D costs. Net income attributable to common stockholders for the fourth quarter of 2016 was $226,000 or $0.02 per share vs net income of $97,000 or $0.01 per share for the same period in 2015. Net income attributable to common stockholders for the fourth quarter of 2016 included a loss from discontinued operations of $108,000 as compared to a loss from discontinued operations of $551,000 in the corresponding period of 2015.

The Company's Adjusted EBITDA at December 31, 2016 was approximately $575,000 from continuing operations as compared to approximately $7.0 million for the corresponding period of 2015. The Company defines EBITDA as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA is defined as EBITDA before research and development costs related to the Medical Isotope project, impairment charges on tangible and intangible assets and write-off of prepaid fees resulting from tangible asset impairment loss. Both EBITDA and Adjusted EBITDA are not measures of performance calculated in accordance with Generally Accepted Accounting Principles in the United States of America ("GAAP"), and should not be considered in isolation of, or as a substitute for, earnings as an indicator of operating performance or cash flows from operating activities as a measure of liquidity. The Company believes the presentation of EBITDA and Adjusted EBITDA is relevant and useful by enhancing the readers' ability to understand the Company's operating performance. The Company's management utilizes EBITDA and Adjusted EBITDA as a means to measure performance. The Company's measurements of EBITDA and Adjusted EBITDA may not be comparable to similar titled measures reported by other companies. The table below reconciles EBITDA and Adjusted EBITDA, both non-GAAP measures, to GAAP numbers for income (loss) from continuing operations for the three and twelve months ended December 31, 2016 and 2015.

                                     Quarter Ended      Twelve Months Ended 
                                     December 31,          December 31,     
                                      (Unaudited)           (Unaudited)     
                                 --------------------  -------------------- 
(In thousands)                      2016       2015       2016       2015   
-------------------------------- ---------  ---------  ---------  --------- 
Income (loss) from continuing                                               
 operations                      $     218  $     259  $ (13,263) $     (63)
                                                                            
                                                                            
Adjustments:                                                                
  Depreciation & amortization        1,179        895      4,165      3,717 
  Interest income                      (32)       (17)      (110)       (53)
  Interest expense                     112         99        489        489 
  Interest expense - financing                                              
   fees                                  8         57        108        228 
  Income tax expense (benefit)          99        418     (2,994)       543 
                                 ---------  ---------  ---------  --------- 
                                                                            
EBITDA                               1,584      1,711    (11,605)     4,861 
                                 ---------  ---------  ---------  --------- 
                                                                            
Research and development costs                                              
 related to medical Isotope                                                 
 project                               294        760      1,489      2,114 
Impairment loss on tangible                                                 
 assets                                  —          —      1,816          — 
Impairment loss on intangible                                               
 assets                                  —          —      8,288          — 
Write-off of prepaid fees                                                   
 resulting from impairment loss                                             
 on tangible asset                       —          —        587          — 
                                 ---------  ---------  ---------  --------- 
                                                                            
Adjusted EBITDA                  $   1,878  $   2,471  $     575  $   6,975 
                                 =========  =========  =========  ========= 
                                                                            
                                                                            
                                                                            

The tables below present certain financial information for the business segments, which exclude allocation of corporate expenses:

                     Three Months Ended            Twelve Months Ended      
                      December 31, 2016             December 31, 2016       
                         (Unaudited)                    (Audited)           
                ----------------------------  ----------------------------- 
(In thousands)  Treatment  Services  Medical  Treatment   Services  Medical 
--------------- --------- --------- --------  ---------  --------- -------- 
Net revenues    $   9,422 $   4,030 $      —  $  32,253  $  18,966 $      — 
Gross profit        2,735       693        —      4,015      3,069        — 
Segment profit                                                              
 (loss)             1,694        62     (294)    (7,106)       744   (1,489)
                                                                            
                                                                            
                                                                            
                     Three Months Ended            Twelve Months Ended      
                      December 31, 2015             December 31, 2015       
                         (Unaudited)                    (Audited)           
                ----------------------------  ----------------------------- 
(In thousands)  Treatment  Services  Medical  Treatment   Services  Medical 
--------------- --------- --------- --------  ---------  --------- -------- 
Net revenues    $   9,615 $   5,504 $      —  $  41,318  $  21,065 $      — 
Gross profit        2,645     1,251        —     10,910      3,441        — 
Segment profit                                                              
 (loss)             1,439       913     (760)     6,563      1,178   (2,114)
                                                                            

Conference Call

Perma-Fix will host a conference call at 11:00 AM ET on Wednesday, March 22, 2017. The call will be available on the Company's website at www.perma-fix.com, or by calling 877-407-0778 for U.S. callers, or +1 201-689-8565 for international callers. The conference call will be led by Dr. Louis F. Centofanti, Chief Executive Officer, Ben Naccarato, Vice President and Chief Financial Officer, and Mark J. Duff, Executive Vice President of Perma-Fix Environmental Services, Inc.

A webcast will also be archived on the Company's website and a telephone replay of the call will be available approximately one hour following the call, through midnight March 29, 2017, and can be accessed by calling: 877-481-4010 (U.S. callers) or +1-919-882-2331 (international callers) and entering conference ID:10292.

About Perma-Fix Environmental Services

Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the Department of Energy ("DOE"), the Department of Defense ("DOD"), and the commercial nuclear industry. The Company's nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The Company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOD, and commercial facilities, nationwide.

Please visit us on the World Wide Web at http://www.perma-fix.com.

This press release contains "forward-looking statements" which are based largely on the Company's expectations and are subject to various business risks and uncertainties, certain of which are beyond the Company's control. Forward-looking statements generally are identifiable by use of the words such as "believe", "expects", "intends", "anticipate", "plan to", "estimates", "projects", and similar expressions. Forward-looking statements include, but are not limited to: expect to achieve growth and improved results in 2017; anticipate first quarter and year end 2017 will be a year of growth and improved results for our Treatment Segment; expect the first quarter of 2017 to be significantly improved compared to the first quarter of last year; benefit of closing M&EC facility; receipt of restricted finite risk sinking funds of approximately $3.5 million by the second quarter of 2017; well positioned heading into 2017; and finalizing an agreement with private investor to fund medical subsidiary. These forward-looking statements are intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. While the Company believes the expectations reflected in this news release are reasonable, it can give no assurance such expectations will prove to be correct. There are a variety of factors which could cause future outcomes to differ materially from those described in this release, including, without limitation, future economic conditions; industry conditions; competitive pressures; our ability to apply, commercialize, and market our new technologies; the government or such other party to a contract granted to us fails to abide by or comply with the contract or to deliver waste as anticipated under the contract; Perma-Fix Medical obtains necessary financing or capital to complete its development; regulatory approvals; that Congress provides continuing funding for the DOD's and DOE's remediation projects; ability to obtain new foreign and domestic remediation contracts; our ability to fund the commercialization of our technology; and the additional factors referred to under "Risk Factors" and "Special Note Regarding Forward-Looking Statements" of our 2016 Form 10-K. The Company makes no commitment to disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that bear upon forward-looking statements.

Please visit us on the World Wide Web at http://www.perma-fix.com.

FINANCIAL TABLES FOLLOW

                                                                            
                   PERMA-FIX ENVIRONMENTAL SERVICES, INC.                   
                   CONSOLIDATED STATEMENTS OF OPERATIONS                    
                                                                            
                                                                            
                                   Three Months Ended    Twelve Months Ended
                                      December 31,          December 31,    
                                  --------------------  --------------------
                                     2016       2015       2016       2015  
                                  --------------------  --------------------
(Amounts in Thousands, Except                                               
 for Per Share Amounts)                (Unaudited)            (Audited)     
------------------------------------------------------  --------------------
                                                                            
Net revenues                     $  13,452  $  15,119  $  51,219  $  62,383 
Cost of goods sold                  10,024     11,223     44,135     48,032 
                                  ---------  ---------  ---------  ---------
  Gross profit                       3,428      3,896      7,084     14,351 
                                                                            
Selling, general and                                                        
 administrative expenses             2,562      2,334     10,724     10,996 
Research and development               477        802      2,046      2,302 
Gain on disposal of property and                                            
 equipment                             (13)       (57)         2        (80)
Impairment loss on tangible                                                 
 assets                                  —          —      1,816          — 
Impairment loss on intangible                                               
 assets                                  —          —      8,288          — 
                                  ---------  ---------  ---------  ---------
  Income (loss) from operations        402        817    (15,792)     1,133 
                                                                            
Other income (expense):                                                     
Interest income                         32         17        110         53 
Interest expense                      (112)       (99)      (489)      (489)
Interest expense-financing fees         (8)       (57)      (108)      (228)
Other                                    3         (1)        22         11 
                                  ---------  ---------  ---------  ---------
Income (loss) from continuing                                               
 operations before taxes               317        677    (16,257)       480 
Income tax expense (benefit)            99        418     (2,994)       543 
                                  ---------  ---------  ---------  ---------
Income (loss) from continuing                                               
 operations, net of taxes              218        259    (13,263)       (63)
                                                                            
Loss from discontinued                                                      
 operations, net of taxes             (108)      (551)      (730)    (1,864)
                                  ---------  ---------  ---------  ---------
  Net income (loss)                    110       (292)   (13,993)    (1,927)
                                  ---------  ---------  ---------  ---------
                                                                            
Net loss attributable to non-                                               
 controlling interest                 (116)      (389)      (588)      (877)
                                  ---------  ---------  ---------  ---------
                                                                            
Net income (loss) attributable                                              
 to Perma-Fix Environmental                                                 
 Services, Inc. common                                                      
 stockholders                    $     226  $      97  $ (13,405) $  (1,050)
                                  =========  =========  =========  =========
                                                                            
Net income (loss) per common                                                
 share attributable to Perma-Fix                                            
 Environmental Services, Inc.                                               
 stockholders - basic and                                                   
 diluted:                                                                   
Continuing operations            $     .03  $     .06  $   (1.09) $     .07 
Discontinued operations               (.01)      (.05)      (.06)      (.16)
                                  ---------  ---------  ---------  ---------
  Net income (loss) per common                                              
   share                         $     .02  $     .01  $   (1.15) $    (.09)
                                  =========  =========  =========  =========
                                                                            
                                                                            
Number of common shares used in                                             
 computing net income (loss) per                                            
 share:                                                                     
Basic                               11,669     11,544     11,608     11,516 
Diluted                             11,679     11,581     11,608     11,552 
                                                                            
                                                                            
                                                                            
                   PERMA-FIX ENVIRONMENTAL SERVICES, INC.                   
                        CONSOLIDATED BALANCE SHEETS                         
                                 (Audited)                                  
                                                                            
                                                                            
(Amounts in Thousands, Except for Share      December 31,     December 31,  
 and Per Share Amounts)                          2016             2015      
----------------------------------------------------------------------------
                                                                            
ASSETS                                                                      
Current assets:                                                             
  Cash and equivalents                     $           163  $         1,534 
  Account receivable, net of allowance for                                  
   doubtful accounts of $272 and $1,474                                     
   respectively                                      8,705            9,673 
  Unbilled receivables                               2,926            4,569 
  Other current assets                               2,728            4,306 
  Assets of discontinued operations                                         
   included in current assets, net of                                       
   allowance for doubtful accounts of $0                                    
   for each period presented                            85               34 
                                           ---------------- ----------------
    Total current assets                            14,607           20,116 
                                                                            
Net property and equipment                          17,115           19,993 
Property and equipment of discontinued                                      
 operations, net of accumulated                                             
 depreciation of $10 for each period                                        
 presented                                              81              531 
Intangibles and other assets                        33,264           42,273 
Other assets related to discontinued                                        
 operations                                            268                — 
                                           ---------------- ----------------
    Total assets                           $        65,335  $        82,913 
                                           ================ ================
                                                                            
LIABILITIES AND STOCKHOLDERS' EQUITY                                        
Current liabilities                        $        15,780  $        16,619 
Current liabilities related to                                              
 discontinued operations                               958              531 
                                           ---------------- ----------------
    Total current liabilities                       16,738           17,150 
                                                                            
Long-term liabilities                               16,080           18,997 
Long-term liabilities related to                                            
 discontinued operations                               361            1,064 
                                           ---------------- ----------------
    Total liabilities                               33,179           37,211 
Commitments and Contingencies                                               
Series B Preferred Stock of subsidiary,                                     
 $1.00 par value; 1,467,396 shares                                          
 authorized, 1,284,730 shares issued and                                    
 oustanding, liquidation value $1.00 per                                    
 share plus accrued and unpaid dividends                                    
 of $931 and $867, respectively                      1,285            1,285 
Stockholders' equity:                                                       
  Preferred Stock, $.001 par value;                                         
   2,000,000 shares authorized,no shares                                    
   issued and outstanding                                —                — 
  Common Stock, $.001 par value;                                            
   30,000,000 shares authorized,                                            
   11,677,025 and 11,551,232 shares                                         
   issued, respectively; 11,669,383 and                                     
   11,543,590 shares outstanding,                                           
   respectively                                         11               11 
  Additional paid-in capital                       106,048          105,556 
  Accumulated deficit                              (74,213)         (60,808)
  Accumulated other comprehensive income              (162)            (117)
  Less Common Stock in treasury at cost:                                    
   7,642 shares                                        (88)             (88)
                                           ---------------- ----------------
    Total Perma-Fix Environmental                                           
     Services, Inc. stockholders' equity            31,596           44,554 
                                           ---------------- ----------------
  Non-controlling interest                            (725)            (137)
                                           ---------------- ----------------
      Total stockholders' equity                    30,871           44,417 
                                           ---------------- ----------------
                                                                            
    Total liabilities and stockholders'                                     
     equity                                $        65,335  $        82,913 
                                           ================ ================
                                                                            
   Contacts:David K. WaldmanUS Investor RelationsCrescendo Communications, LLC(212) 671-1021Herbert StraussEuropean Investor [email protected]+43 316 296 316

Source: Perma-Fix Environmental Services, Inc.

Categories

Press Releases

Next Articles